Conclusion:
While this case was treated successfully without complications, it serves as an addition to the literature describing the clinical features of children who developed NS in the setting of a COVID-19. This will help medical providers in the management and future prognostication of the disease. This case additionally can serve as a basis for case control studies assessing whether COVID-19 infection (exposure) is a risk factor for the development of new onset or relapse of nephrotic syndrome (outcome) in children. To date, this is only the fourth pediatric case report on a new onset NS associated with a COVID-19 infection.